MML INVESTORS SERVICES, LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 701059
SPRINGFIELD, MA
Position in TAK
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,434,651
-$153,096 QoQ
Shares Held
77,465
-23.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MML INVESTORS SERVICES, LLC holds $17,040,391 across 15 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
39,210 | $4,635,014 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
66,778 | $2,011,353 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
90,546 | $1,879,734 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,952 | $1,750,476 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
77,465 | $1,434,651 | |
| 6 | HLN |
Haleon plc
|
119,786 | $1,199,057 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
89,343 | $1,110,533 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
8,151 | $1,073,812 |
All Filings in TAK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,434,651 | 77,465 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $1,587,747 | 101,844 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,312,153 | 89,628 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,249,616 | 80,829 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,030,282 | 69,286 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $822,905 | 62,153 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $584,413 | 41,098 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $473,772 | 36,613 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $609,784 | 43,901 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $627,765 | 43,992 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $599,663 | 38,763 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $435,324 | 27,710 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $324,853 | 19,712 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $434,335 | 27,842 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $317,816 | 24,504 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $301,803 | 21,496 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $298,844 | 20,869 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $270,841 | 19,871 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $393,201 | 24,005 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $401,614 | 23,863 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $682,905 | 37,399 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $600,509 | 32,995 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $509,189 | 28,542 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $483,787 | 26,982 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $426,163 | 28,074 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||